Core Viewpoint - The article emphasizes the importance of guiding the cross-border layout of industrial and supply chains, highlighting that "going global" is a natural economic progression for major countries, and it is essential to focus on Gross National Income (GNI) alongside Gross Domestic Product (GDP) to foster a positive interaction between the Chinese economy and the wealth of its citizens [1] Group 1: Current Status of China's Global Investment - Since the 18th National Congress, China has accelerated its integration into global industrial and supply chains, solidifying its position as a major investment country, with foreign direct investment projected to reach $192.2 billion in 2024, maintaining a top-three global ranking for 13 consecutive years [2] - By the end of 2024, China's cumulative foreign investment is expected to exceed $3 trillion, with over 52,000 enterprises established overseas across 190 countries and regions, and total overseas assets exceeding $9 trillion [2] - China's foreign investment has significantly supported domestic development, facilitated the internationalization of products and services, and contributed positively to the improvement of living standards in host countries [2] Group 2: Strategic Recommendations for Overseas Investment - Effective implementation of foreign investment management is crucial, which includes establishing a comprehensive legal framework and regulatory system for foreign investments, ensuring compliance and oversight throughout the investment process [3] - Optimizing the overseas comprehensive service system is necessary, enhancing public services and integrating various professional services to support companies going global [3] - Expanding the functionality of overseas economic and trade cooperation zones is recommended, focusing on infrastructure development and collaboration with domestic industrial parks to better serve domestic industrial upgrades and international cooperation [4] Group 3: Strengthening Partnerships and Risk Management - It is important to improve the network of partnerships in the industrial and supply chain, promoting international cooperation and facilitating trade and investment liberalization with global southern countries [4] - Establishing a robust overseas risk prevention and benefit protection system is essential, which includes conducting risk assessments, providing timely warnings, and ensuring compliance in overseas operations [5] - Strengthening bilateral investment protection agreements and effectively managing various emergencies will help safeguard overseas enterprises, projects, and personnel [5]

Group 1: Stock Resumption - Baina Qiancheng plans to acquire 100% of Zhonglian Century, a leading digital marketing service provider in the telecommunications industry, and will resume trading [1] - Yichang Technology will have Weiran Partners become its controlling shareholder, leading to stock resumption [1] Group 2: External Investments and Daily Operations - Zhongwei Co., Ltd. signed a strategic cooperation framework agreement with Xinwanda to collaborate on precursor product technology development, product supply, cathode material development, and global capacity layout [2] - Zhongding Co., Ltd. plans to establish a joint venture to engage in joint assembly of robotic products to support complete machine assembly [2] - Huadian Technology signed contracts worth 265 million yuan for six major pipelines for ultra-supercritical power plants and a 159 million yuan digital business contract for a high-altitude renewable energy site [2] - Unigroup Guowei's wholly-owned subsidiary plans to jointly invest with a subsidiary of CATL to establish a company focused on automotive domain control chips [2] - Haike Xinyuan signed a strategic cooperation agreement with Faenlight, expecting a supply of 270,000 tons of electrolyte solvents and additives [3] - Jinlongyu plans to establish a 1.5 billion yuan industrial merger and acquisition fund with Investment Control Donghai, focusing on its main business while considering investments and mergers in the solid-state battery industry chain [3] - Hengsheng Energy's subsidiary signed a sample testing agreement for diamond heat dissipation products with chip technology developer Company H [3] - Ruisheng Intelligent secured a procurement project for domestic computing power equipment and supporting services worth 152 million yuan [4] - Guangju Energy signed a strategic cooperation agreement with China General Nuclear Power Corporation Guangdong [5] - Senyuan Co., Ltd. signed a 26.78 million yuan contract for the construction of a computing power cluster integration project with an affiliated party [6] - ST Jianyi's controlling shareholder waived 1.4 billion yuan of the company's debt principal and 8.8967 million yuan in interest, and donated 400 million yuan in cash assets [7]

Asset Restructuring - Aier Eye Hospital (300015.SZ) plans to acquire partial equity stakes in 39 institutions including Bozhou Aier and Lianyungang Aier for a total transaction amount of 963 million yuan. This acquisition will enhance the company's shareholding in related hospitals and strengthen its market position while improving profitability and competitiveness through synergies and scale effects [2] - Gaozheng Min Explosives (002827.SZ) is jointly purchasing 100% equity of Heilongjiang Overseas Explosive Equipment Co., Ltd. from Heilongjiang Overseas Real Estate Development Group Co., Ltd. for a total of 342 million yuan, acquiring 67% of the equity. This acquisition will address production capacity shortages by transferring 31,000 tons of industrial explosive capacity to Tibet [2] Major Contracts - Enhua Pharmaceutical (002262.SZ) has signed an exclusive commercial cooperation agreement with Green Leaf Pharmaceutical and its subsidiary Green Leaf Jiaoda for three long-acting injectable antipsychotic products in mainland China. The agreement includes a one-time payment of 20 million USD and a sales target of at least 2.7 billion yuan from 2026 to 2035 [3] Shareholding Changes - Zhangyuan Tungsten (002378.SZ) has completed a share reduction plan, selling 23.99 million shares (1.9968% of total shares) between November 7 and December 22 at an average price of 12.04 yuan per share. After the reduction, the controlling shareholder holds 56.7275% of the company [4] - Chaojie Co., Ltd. (301005.SZ) saw its controlling shareholder reduce its stake by 974,400 shares (0.73% of total shares) due to personal financial needs, with the shareholding decreasing from 46.63% to 45.89% [4] - Luxin Investment (600783.SH) plans to reduce its stake by up to 7.44 million shares (up to 1% of total shares) between January 20 and April 19, 2026 [5] - Sunshine Power (300274.SZ) reported that several executives completed their share reduction plans, while one executive decided to terminate their plan early, with no significant impact on company control [6] - Tuo Jing Technology (688072.SH) reported a reduction of 1.83 million shares (0.65% of total shares) by a major shareholder, with no impact on company governance [7] - Caesar Travel (000796.SZ) plans to reduce its stake by up to 48.11 million shares (up to 3% of total shares) between January 20 and April 19, 2026, due to financial needs [7] Hot Stock Movements - Victory Energy (001331.SZ) has seen its stock price hit the limit up for nine consecutive trading days, with a cumulative increase of 135.86%. The company may apply for a trading suspension if prices continue to rise [8] - Hongda Electronics (300726.SZ) reported that its indirect holding in Jiangsu Zhanxin Semiconductor Technology Co., Ltd. has not changed significantly despite the latter's IPO application, which remains uncertain [8] - Sega Technology (002796.SZ) is experiencing abnormal stock price fluctuations, with a cumulative increase of 21.56%. The company is in the process of extending an exclusivity agreement related to an investment in Guangcai Xincheng [9] Capital Increase and Expansion - Changan Automobile (000625.SZ) has publicly listed a capital increase project for its subsidiary, Deep Blue Automobile, with two investors confirmed to have the qualifications to acquire shares, maintaining Changan's 50.9959% ownership [10] External Investments - SANY Renewable Energy (688349.SH) has approved a plan to use up to 9.5 billion yuan of idle funds for low-risk financial products, ensuring that it does not affect its main business operations [11][12]

步长制药(603858.SH)公告称，公司控股子公司步长众鑫康医药拟出资180万元，与湖北合俊腾辉贸易有 限公司共同投资设立步长互联网（湖北）有限公司，注册资本为300万元，步长众鑫康医药持股比例为 60%。该投资事项无需提交股东会审议，不会对公司本年度财务状况和经营成果造成重大影响，但从长 远来看，将对公司持续经营能力和企业综合竞争力产生积极影响。新公司可能面临宏观政策调控、市场 变化及经营管理等因素的影响，后续投资收益存在不确定性。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 ...

中创智领公告称，第六届董事会第二十次会议审议多项议案。同意以1000万元自有资金设全资子公司， 再由公司出资2.99亿元、子公司出资100万元设产业投资合伙企业开展对外投资。预计2026年日常关联 交易总额上限为51.04亿元，该议案将提交股东会审议。还同意修订《公司章程》及其附件，删除类别 股东相关条款并适当修订部分条款，同时同意召开2026年第一次临时股东会及A、H股类别股东会。 ...

中创智领公告称，公司拟以自有资金出资1000万元设立全资子公司郑州中创智领未来投资管理有限公 司，并由公司作为有限合伙人出资2.99亿元、该投资管理公司作为普通合伙人出资100万元，设立中创 智领（郑州）产业投资合伙企业（有限合伙），合称"新产业投资平台"。2025年12月22日，公司第六届 董事会第二十次会议已审议通过相关议案。新产业投资平台将围绕公司未来5 - 10年战略开展对外投 资，聚焦主业产业链、战略性新兴产业等方向。不过，设立尚需办理工商注册登记，投资收益或受多因 素影响。 ...

Core Viewpoint - Jindalai (688057) has announced an investment of 30 million yuan in Beijing Zhongke Hongtai Medical Technology Co., Ltd. to acquire a 10% stake, aiming to optimize its industrial structure and cultivate new profit growth points [1] Group 1: Stock Performance - As of December 22, 2025, Jindalai's stock closed at 12.4 yuan, up 3.77% from the previous trading day, with a total market capitalization of 3.422 billion yuan [1] - The stock opened at 13.0 yuan, reached a high of 13.5 yuan, and a low of 12.38 yuan, with a trading volume of 92.2442 million yuan and a turnover rate of 2.58% [1] Group 2: Investment Details - Jindalai plans to use its own funds of 30 million yuan for the investment, which is classified as a non-proportional capital increase and does not constitute a major asset restructuring or related party transaction [1] - The target company, Beijing Zhongke Hongtai, focuses on the research, production, and sales of medical robot technology and systems, and is incubated by the Chinese Academy of Sciences' Institute of Automation, possessing strong research capabilities and multiple independent intellectual property rights [1] - The products of the target company have entered the special review process for innovative medical devices by the National Medical Products Administration [1]

一、对外投资事项前期公告情况 2025年12月12日，云南临沧鑫圆锗业股份有限公司（以下简称"公司"）第八届董事会第三十二次会议审 议通过《关于对外投资设立控股子公司的议案》，同意公司与昆明哈傈佤企业管理合伙企业（有限合 伙）共同出资1,000万元设立控股子公司云南锗业生物科技有限公司（暂定名，以工商登记信息为 准）。 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记载、误导性陈述或重大遗漏。 成立日期：2025年12月18日 住所：云南省昆明高新技术产业开发区马金铺街道办事处大营社区居委会魁星街666号 经营范围：许可项目：化妆品生产；第三类医疗器械生产；第三类医疗器械经营；检验检测服务；消毒 剂生产（不含危险化学品）；用于传染病防治的消毒产品生产。（依法须经批准的项目，经相关部门批 准后方可开展经营活动，具体经营项目以相关部门批准文件或许可证件为准） 一般项目：细胞技术研 发和应用；生物化工产品技术研发；技术服务、技术开发、技术咨询、技术交流、技术转让、技术推 广；化妆品批发；化妆品零售；技术进出口；货物进出口；健康咨询服务（不含诊疗服务）；日用化学 产品制造；基础化学原料制造（不含危险化学 ...

Core Viewpoint - The company Tianzhong Precision Machinery (300461.SZ) has approved an investment in Shenzhen Ruisheng New Energy Technology Co., Ltd., acquiring a total of 38.32% equity stake through capital increase and share transfer [1] Investment Details - The company will invest a total of RMB 25 million to subscribe for an additional registered capital of RMB 7.8125 million in Ruisheng New Energy, obtaining 23.81% equity [1] - Additionally, the company plans to acquire 14.5122% equity from shareholder Xie Jian for RMB 16.5901112 million, corresponding to a registered capital of RMB 4.7618 million [1] - After the completion of the share transfer, the company's total registered capital contribution in Ruisheng New Energy will amount to RMB 12.5743 million, representing a 38.32% equity stake [1] Management Authorization - The board of directors has authorized the management team to sign investment-related agreements and handle all matters related to this transaction [1]

(2)复星医药产业拟出资126,948.1633万元认缴标的公司20,086.7347万元新增注册资本(即"本次认购新增 注册资本"或"本次认购")。 中国经济网北京12月16日讯复星医药（600196）(600196.SH)昨晚发布对外投资公告。为聚焦未被满足 的临床需求,进一步丰富集团中枢神经系统治疗领域的创新产品管线矩阵、完善市场布局，打造诊疗一 体、多技术路径协同的解决方案，控股子公司复星医药产业拟出资共计141,248.1633万元控股投资绿谷 医药，包括： (1)复星医药产业拟出资14,300万元受让转让方(即市隐投资、识璧润咨询)合计持有的标的公司2,015万元 注册资本(即"本次转让")。 根据标的公司的管理层报表(合并口径、未经审计)，截至2023年12月31日，标的公司的总资产为108,089 万元、所有者权益为2,298万元、负债总额为105,791万元；2023年，标的公司实现营业收入37,773万 元、税前利润-981万元、净利润3,148万元。 经安永华明会计师事务所(特殊普通合伙)上海分所审计(合并口径)，截至2024年12月31日，标的公司的 总资产为97,359万元、所有者权 ...